This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bruce Michael Bechle: Innovator in HSD17B13 Inhibitors
Introduction
Bruce Michael Bechle is an inventor based in Oakdale, CT (US). He is known for his work in the field of pharmaceutical compounds, particularly focusing on HSD17B13 inhibitors and degraders. His innovative approach aims to address significant health issues such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Latest Patent Applications
Bruce Michael Bechle has submitted a patent application for "HSD17B13 INHIBITORS AND/OR DEGRADERS." This application describes compounds of Formula I, detailing their potential use as HSD17B13 inhibitors and/or degraders. The pharmaceutical compositions containing these compounds are intended for treating conditions like NAFLD and NASH.
Conclusion
Bruce Michael Bechle is a dedicated inventor whose work in HSD17B13 inhibitors holds promise for advancing treatments for liver diseases. His contributions to pharmaceutical innovation reflect a commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile